BI
DMAAU

Bulldog Investors’s Drugs Made In America Acquisition Corp Units DMAAU Stock Holding History

Bulldog Investors’s Portfolio DMAAU Stock Details DMAAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-57,300
Closed -$591K – 217
2025
Q2 		$591K Sell
57,300
-72,964
-56% -$747K 0.15% 100
2025
Q1 		$1.32M Buy
+130,264
New +$1.31M 0.36% 63

Other funds holding DMAAU

KC
Kryger Capital London, United Kingdom $1.75B AUM 102.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
RCM
Robinson Capital Management Grosse Pointe Farms, Michigan $226M AUM 6.92% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bulldog Investors's DMAAU Position: Q3 2025 in Review

Bulldog Investors sold out of Drugs Made In America Acquisition Corp Units (DMAAU) in Q3 2025, closing a stake of 57,300 shares — an estimated $591K sold.

Bulldog Investors first reported a position in DMAAU in Q1 2025 and held it in 2 quarters. The position peaked at $1.32M in Q1 2025. 8 funds tracked by Wall St. Rank hold DMAAU as of Q3 2025.

  • Bulldog Investors reported no remaining Drugs Made In America Acquisition Corp Units position as of Q3 2025 after selling out during the quarter.
  • Bulldog Investors sold 57,300 Drugs Made In America Acquisition Corp Units shares in Q3 2025, an estimated $591K.
  • Bulldog Investors first reported a position in Drugs Made In America Acquisition Corp Units in Q1 2025 and held it in 2 quarters.
  • Bulldog Investors's Drugs Made In America Acquisition Corp Units position peaked at $1.32M in Q1 2025.
  • 8 funds tracked by Wall St. Rank held Drugs Made In America Acquisition Corp Units as of Q3 2025.

Based on Bulldog Investors's 13F filing for Q3 2025, filed 14 Nov 2025.